Articles

Antibe Therapeutics Reports 2018 Year-End Financial and Operating Results | Business Wire

Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases | Business Wire

Bon week-end a toutes/tous

ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID® (Pimavanserin) | Business Wire

U.S. Dialysis Catheter Market Analysis & Outlook to 2024 - MedCore - ResearchAndMarkets.com | Business Wire

22nd Century宣布新的非转基因极低尼古丁烤烟和白肋烟变种 | Business Wire

PharmaCyte Biotech Discusses Importance of Shrinking Pancreatic Cancer Tumors in Latest Q

recommandations

Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries

Insulet Presents Positive Clinical Trial Results for the Omnipod® Horizon™ Hybrid Closed-Loop System at the American Diabetes Association's 78th Scientific Sessions | Business Wire

Dashboard - Meine Einschätzungen - sharewise.com